Task: Answer the multiple choice question.
Question: Which drug exhibits a -3.172% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC1CCN(CCCNC(=O)c2n[nH]c(=O)c3ccccc23)CC1
b. CCCn1c(C2CCCN2c2nc(C)cs2)nc2cc(Cl)c(Cl)cc21
Answer: a. CC1CCN(CCCNC(=O)c2n[nH]c(=O)c3ccccc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(CCCNC(=O)c2n[nH]c(=O)c3ccccc23)CC1
CC1CCN(CCCNC(=O)c2n[nH]c(=O)c3ccccc23)CC1
N-[3-(4-methylpiperidin-1-yl)propyl]-4-oxo-3H-phthalazine-1-carboxamide